CRISPR THERAPEUTICS AG Capital Expenditures Incurred but Not yet Paid
CRISPR THERAPEUTICS AG (CRSP) reported Capital Expenditures Incurred but Not yet Paid of $394.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-02-12
- CRISPR THERAPEUTICS AG capital expenditures incurred but not yet paid for the quarter ending 2024-12-31 was $121.00K.
- CRISPR THERAPEUTICS AG capital expenditures incurred but not yet paid for the quarter ending 2024-09-30 was $13.00K.
- CRISPR THERAPEUTICS AG capital expenditures incurred but not yet paid for the quarter ending 2024-06-30 was -$111.00K.
- CRISPR THERAPEUTICS AG capital expenditures incurred but not yet paid for the quarter ending 2024-03-31 was $131.00K, a 95.02% decline year-over-year.
- CRISPR THERAPEUTICS AG capital expenditures incurred but not yet paid for fiscal 2025 was $394.00K, a 155.84% increase from fiscal 2024.
- CRISPR THERAPEUTICS AG capital expenditures incurred but not yet paid for fiscal 2024 was $154.00K, a 78.76% decline from fiscal 2023.
- CRISPR THERAPEUTICS AG capital expenditures incurred but not yet paid for fiscal 2023 was $725.00K, a 65.82% decline from fiscal 2022.
- CRISPR THERAPEUTICS AG capital expenditures incurred but not yet paid for fiscal 2022 was $2.12M, a 74.59% decline from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 3 month as first filed | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $394.00K 10-K · filed 2026-02-12 | ||||
| 2024-12-31 | $121.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $134.00K derived: sum of 2 quarters · filed 2026-02-12 | $23.00K derived: sum of 3 quarters · filed 2026-02-12 | $154.00K 10-K · filed 2026-02-12 | |
| 2024-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$98.00K derived: sum of 2 quarters · filed 2024-11-05 | $33.00K 10-Q · filed 2024-11-05 | $5.00K derived: sum of 4 quarters · filed 2026-02-12 | |
| 2024-06-30 | -$111.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $20.00K 10-Q · filed 2024-08-05 | -$8.00K derived: sum of 3 quarters · filed 2026-02-12 | -$284.00K derived: sum of 4 quarters · filed 2026-02-12 | |
| 2024-03-31 | $131.00K 10-Q · filed 2024-05-08 | $103.00K derived: sum of 2 quarters · filed 2026-02-12 | -$173.00K derived: sum of 3 quarters · filed 2026-02-12 | -$1.78M derived: sum of 4 quarters · filed 2026-02-12 | |
| 2023-12-31 | -$28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | -$304.00K derived: sum of 2 quarters · filed 2026-02-12 | -$1.91M derived: sum of 3 quarters · filed 2026-02-12 | $725.00K 10-K · filed 2026-02-12 | |
| 2023-09-30 | -$276.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$1.88M derived: sum of 2 quarters · filed 2024-11-05 | $753.00K 10-Q · filed 2024-11-05 | -$2.04M derived: sum of 4 quarters · filed 2025-02-11 | |
| 2023-06-30 | -$1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $1.03M 10-Q · filed 2024-08-05 | -$1.77M derived: sum of 3 quarters · filed 2025-02-11 | -$1.87M derived: sum of 4 quarters · filed 2025-02-11 | |
| 2023-03-31 | $2.63M 10-Q · filed 2024-05-08 | $2.66M 10-Q · filed 2023-05-08 | -$165.00K derived: sum of 2 quarters · filed 2025-02-11 | -$262.00K derived: sum of 3 quarters · filed 2025-02-11 | -$1.13M derived: sum of 4 quarters · filed 2025-02-11 |
| 2022-12-31 | -$2.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | -$2.90M derived: sum of 2 quarters · filed 2025-02-11 | -$3.77M derived: sum of 3 quarters · filed 2025-02-11 | $2.12M 10-K · filed 2025-02-11 | |
| 2022-09-30 | -$97.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$969.00K derived: sum of 2 quarters · filed 2023-11-06 | $4.92M 10-Q · filed 2023-11-06 | $7.00M derived: sum of 4 quarters · filed 2024-02-21 | |
| 2022-06-30 | -$872.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $5.02M 10-Q · filed 2023-08-07 | $7.10M derived: sum of 3 quarters · filed 2024-02-21 | $5.83M derived: sum of 4 quarters · filed 2024-02-21 | |
| 2022-03-31 | $5.89M 10-Q · filed 2022-05-09 | $7.97M derived: sum of 2 quarters · filed 2024-02-21 | $6.70M derived: sum of 3 quarters · filed 2024-02-21 | $5.39M derived: sum of 4 quarters · filed 2024-02-21 | |
| 2021-12-31 | $2.08M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $815.00K derived: sum of 2 quarters · filed 2024-02-21 | -$499.00K derived: sum of 3 quarters · filed 2024-02-21 | $8.35M 10-K · filed 2024-02-21 | |
| 2021-09-30 | -$1.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | -$2.58M derived: sum of 2 quarters · filed 2022-11-01 | $6.26M 10-Q · filed 2022-11-01 | $6.81M derived: sum of 4 quarters · filed 2023-02-21 | |
| 2021-06-30 | -$1.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $7.53M 10-Q · filed 2022-08-08 | $8.08M derived: sum of 3 quarters · filed 2023-02-21 | $8.36M derived: sum of 4 quarters · filed 2023-02-21 | |
| 2021-03-31 | $8.85M 10-Q · filed 2022-05-09 | $9.40M derived: sum of 2 quarters · filed 2023-02-21 | $9.67M derived: sum of 3 quarters · filed 2023-02-21 | $10.92M derived: sum of 4 quarters · filed 2023-02-21 | |
| 2020-12-31 | $549.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $827.00K derived: sum of 2 quarters · filed 2023-02-21 | $2.07M derived: sum of 3 quarters · filed 2023-02-21 | $3.41M 10-K · filed 2023-02-21 | |
| 2020-09-30 | $278.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $1.52M derived: sum of 2 quarters · filed 2021-11-03 | $2.86M 10-Q · filed 2021-11-03 | $4.25M derived: sum of 4 quarters · filed 2022-02-15 | |
| 2020-06-30 | $1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $2.58M 10-Q · filed 2021-07-29 | $3.97M derived: sum of 3 quarters · filed 2022-02-15 | $3.69M derived: sum of 4 quarters · filed 2022-02-15 | |
| 2020-03-31 | $1.34M 10-Q · filed 2021-04-27 | $2.72M derived: sum of 2 quarters · filed 2022-02-15 | $2.45M derived: sum of 3 quarters · filed 2022-02-15 | $2.57M derived: sum of 4 quarters · filed 2022-02-15 | |
| 2019-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $1.11M derived: sum of 2 quarters · filed 2022-02-15 | $1.23M derived: sum of 3 quarters · filed 2022-02-15 | $1.81M 10-K · filed 2022-02-15 | |
| 2019-09-30 | -$274.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28 | -$151.00K derived: sum of 2 quarters · filed 2020-10-28 | $428.00K 10-Q · filed 2020-10-28 | ||
| 2019-06-30 | $123.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-27 | $702.00K 10-Q · filed 2020-07-27 | |||
| 2019-03-31 | $579.00K 10-Q · filed 2020-04-28 | ||||
| 2018-12-31 | $334.00K 10-K · filed 2021-02-16 | ||||
| 2018-06-30 | -$182.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-29 | $125.00K 10-Q · filed 2019-07-29 | |||
| 2018-03-31 | $307.00K 10-Q · filed 2019-04-29 | ||||
| 2017-09-30 | -$2.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$855.00K derived: sum of 2 quarters · filed 2018-11-07 | $118.00K 10-Q · filed 2018-11-07 | $6.89M derived: sum of 4 quarters · filed 2019-02-25 | |
| 2017-06-30 | $1.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $2.70M 10-Q · filed 2018-08-07 | $9.46M derived: sum of 3 quarters · filed 2019-02-25 | $9.66M derived: sum of 4 quarters · filed 2019-02-25 | |
| 2017-03-31 | $973.00K 10-Q · filed 2018-05-08 | $7.74M derived: sum of 2 quarters · filed 2019-02-25 | $7.94M derived: sum of 3 quarters · filed 2019-02-25 | $7.87M derived: sum of 4 quarters · filed 2019-02-25 | |
| 2016-12-31 | $6.77M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $6.97M derived: sum of 2 quarters · filed 2019-02-25 | $6.90M derived: sum of 3 quarters · filed 2019-02-25 | $7.01M 10-K · filed 2019-02-25 | |
| 2016-09-30 | $199.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $130.00K derived: sum of 2 quarters · filed 2017-11-08 | $246.00K 10-Q · filed 2017-11-08 | $460.00K derived: sum of 4 quarters · filed 2018-03-08 | |
| 2016-06-30 | -$69.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $47.00K 10-Q · filed 2017-08-10 | $261.00K derived: sum of 3 quarters · filed 2018-03-08 | ||
| 2016-03-31 | $116.00K 10-Q · filed 2017-05-11 | $330.00K derived: sum of 2 quarters · filed 2018-03-08 | |||
| 2015-12-31 | $214.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $246.00K 10-K · filed 2018-03-08 | |||
| 2015-09-30 | $32.00K 10-Q · filed 2016-11-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |